Company History

We’re very proud of what we have accomplished during the last 15 years in translating basic gene expression technologies into a unique platform that is used by more than 95 leading companies worldwide.

Jan 2015

January 2015

  • First Selexis SUREtechnology-Generated Therapeutic Monoclonal Antibody Approved
Apr 2013

April 2013

  • Selexis launches SURE CHO-Mplus Libraries.
  • Selexis sells potential milestone and royalty payments to Ligan Pharmaceuticals.
  • Mar 2011

    March 2011

  • Selexis completes sequencing of the Selexis SURE CHO-M genome.
  • Selexis celebrates 10 years of innovation.
  • Selexis launches SUREvariant screening™ service.
  • Feb 2011

    February 2011

  • Selexis doubles cell line development laboratory space in Geneva, Switzerland.
  • Mar 2009

    March 2009

  • Selexis launches biosimilar cell line development program.
  • Sep 2008

    September 2008

  • Artelis and Selexis report record antibody production levels in CHO cells of over 31 grams per liter.
  • Apr 2007

    April 2007

  • Selexis establishes US subsidiary outside of Boston, MA.
  • Apr 2007

    April 2007

  • Selexis establishes US subsidiary outside of Boston, MA.
  • Feb 2007

    February 2007

  • Selexis expands European production and business operations with new facilities and staff.
  • Jul 2005

    July 2005

  • The company opened its new R&D facility in Plan-les-Ouates.
  • scroll